The global heparin market was valued at USD 7.46 billion in 2024 and is projected to grow to USD 9.02 billion by 2033, reflecting a compound annual growth rate (CAGR) of 2.12% from 2025 to 2033. North America leads the market, accounting for 36% of the global share in 2024. Key drivers include the increasing demand for effective cardiovascular disease treatments, significant R&D inves... https://www.imarcgroup.com/heparin-market